Gunnar Brobert, n/a

Bayer AB

Presentation(s):

• L-1Q - Acute Kidney Injury in Patients with Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-based Study in the United Kingdom

  Monday, August 23, 2021
  5:30 PM – 6:30 PM US Eastern Time